Chinese expert consensus on whole-process management of oxaliplatin-induced hypersensitivity reactions (2024 edition)
Oxaliplatin serves as a basic therapeutic agent for various malignant tumors. Oxaliplatin-induced hypersensitivity reactions are potentially life-threatening, and frequently lead to treatment discontinuation. Alternative therapies may be less effective and/or more expensive, with varying tolerabilit...
Zapisane w:
| 1. autor: | |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Editorial Office of China Oncology
2024-08-01
|
| Seria: | Zhongguo aizheng zazhi |
| Hasła przedmiotowe: | |
| Dostęp online: | http://www.china-oncology.com/fileup/1007-3639/PDF/1725946608430-1858045159.pdf |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|